Cepi (Coalition For Epidemic Preparedness Innovations) company information, Employees & Contact Information

BMFTR boosts international vaccine initiative CEPI CEPI

CEPI backs new research into vaccines against multiple deadly filoviruses CEPI

Serum Institute of India and CEPI supercharge pandemic response preparedness targeting H5N1 CEPI

New global collaboration uses experts and AI to spot the next pandemic CEPI

CEPI partners with AVAREF to boost clinical trial application reviews in Africa CEPI

Leading science labs in Korea join world’s largest vaccine testing network CEPI

Top health and science experts join coalition preparing for future pandemic threats CEPI

West African leaders commit to advance Lassa Fever vaccine for the region CEPI

World-first library of vaccine-enhancing adjuvants launches CEPI

Pandemic speed: How rapid-response science saves lives CEPI

New vaccine set for human trials in Nipah outbreak hotspot CEPI

Building a global AI platform for pandemic preparedness CEPI

CEPI partners with University of Bergen to map vaccine development landscape CEPI

CEPI partners with Ethris to increase access to RNA vaccines through spray-dry technique CEPI

Landmark African-led research to map the extent of Rift Valley fever impact CEPI

CEPI signs new collaborative agreement with US Dept of Defense to expand protection against disease outbreaks CEPI

Moving forward the vaccine supply chain in Africa CEPI

R&D experts to create playbooks that map immune markers in deadly diseases CEPI

New study shows all-in-one coronavirus vaccines could save millions of lives in future pandemics CEPI

New Mpox vaccine study to launch in outbreak-affected DRC CEPI

Pioneering vaccine tech could pave the way for all-in-one shots against rapidly mutating viruses CEPI

Progress and results CEPI

Pioneering research to develop all-in-one vaccine against some of the world’s most deadly diseases CEPI

Exploiting fungus growth for rapid and affordable vaccine development CEPI

New CEPI funding to spearhead pandemic preparedness research CEPI

Pushing mRNA vaccine development timelines to new speeds CEPI

How disease survivors’ antibodies shape lifesaving vaccines CEPI

Faster outbreak survivor sample collection can help stop pandemics in their tracks CEPI

New protein vaccine approach could enable faster responses to Disease X CEPI

Boosting access to mRNA vaccines through innovative mRNA delivery platform CEPI

Public health expert Dr. Kesete Admasu joins CEPI Board CEPI

The world should prepare now for a potential H5N1 flu pandemic, experts warn CEPI

mRNA vaccines – What they are, and what they are not CEPI

CEPI statement on the adoption of the Pandemic Agreement CEPI

Senegal helps to power Africa’s drive for vaccine independence CEPI

Richard Hatchett reflects on a “banner year for viruses” and looks ahead to 2025 CEPI

Nagasaki University’s ‘Nanoball’ technology could help defeat the next Disease X CEPI

AI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses CEPI

100 Days Mission: are we ready for the next pandemic? CEPI

CEPI appoints Executive Director of People and Organisation CEPI

The Pandemic Agreement - What it is, and what it is not CEPI

CEPI and Micron Biomedical accelerate needle-free vaccines against Disease X CEPI

New single-shot vaccine could offer controlled release of multiple doses over six months CEPI

Boosting advanced-stage clinical trial capacity in East and Central Africa to combat regional epidemic threats CEPI

Progressing the 100 Days Mission for greater global health security CEPI

South Africa’s Afrigen to develop human mRNA Rift Valley fever vaccine CEPI

Protein subunit vaccines – What they are, and what they are not CEPI

Viral vector vaccines – What they are, and what they are not CEPI

Responsibly unleashing artificial intelligence in pandemic preparedness CEPI

CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines CEPI

New funding for vaccine to protect against deadly MERS coronavirus CEPI

Transatlantic scientists to transition traditional vaccine development onto rapid-response platform for faster outbreak control CEPI

Groundbreaking study in Rwanda to unlock new insights into Marburg virus immunity CEPI

Accessing innovation: Aurélia Nguyen’s drive for science to benefit all CEPI

Mpox CEPI

Establishing vaccine safety benchmarking in Africa for African vaccines CEPI

Valneva expands access to Asia for its chikungunya vaccine with Serum CEPI

Bringing together all the pieces of the Lassa fever vaccine puzzle CEPI

New project aims to bolster global vaccine preparedness against SARS-CoV-1 and SARS-CoV-2 CEPI

Scientists launch largest-ever study tracking chikungunya burden in East Africa CEPI

Calls for Proposals CEPI

Pandemic speed: How rapid-response science saves lives Gavi, the Vaccine Alliance

Why we exist CEPI

CEPI 2.0 and the 100 Days Mission CEPI

New study to assess mpox vaccine in pregnant women and infants CEPI

Enabling science CEPI

Enabling equitable access CEPI

Priority pathogens CEPI

CEPI extends collaboration with Novavax to advance development and manufacture of COVID-19 vaccine CEPI

Promising human Rift Valley fever vaccine to enter Phase II clinical trials in Kenya CEPI

Senegal joins CEPI in the fight against pandemics CEPI

Serum Institute of India joins CEPI global network to boost production of affordable outbreak vaccines CEPI

Global community comes together in support of 100 Days Mission and pledges over $1.5 billion for CEPI's pandemic-busting plan CEPI

Lassa fever CEPI

CEPI launches plan to tackle risk of future pandemics and epidemics CEPI

Accelerating access to the world's first Chikungunya vaccine CEPI

Survey launched by CEPI to track multinational vaccine manufacturing capacity for use in future epidemics and pandemics CEPI

What will it take? Global coalition outlines how to beat the next Disease X pandemic in 100 days CEPI

BioNTech and CEPI expand partnership to strengthen Africa’s mRNA vaccine ecosystem CEPI

CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019 CEPI

CEPI puts new biosecurity strategy at heart of 100 Days Mission CEPI

News CEPI

The Global Pandemic Preparedness Summit 2024: Outcomes Report CEPI

CEPI partners with University of California, Davis to advance a vaccine against potentially deadly Rift Valley fever virus into clinical trials CEPI

Using AI to speed up vaccine development against Disease X CEPI

$2 billion required to develop a vaccine against the COVID-19 virus CEPI

Marburg – What it is, and what it is not CEPI

CEPI opens Call to develop heat-stable vaccine tech for use against epidemic and pandemic threats CEPI

CEPI appoints Aurélia Nguyen as Deputy CEO CEPI

CEPI expands partnership with Valneva with $41.3 million to support broader access to world’s first Chikungunya vaccine CEPI

New research to investigate next generation ‘trans-amplifying’ mRNA vaccines CEPI

CEPI opens Call to evaluate fractional COVID-19 booster and third shots as part of efforts to stretch global vaccine supply CEPI

CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine CEPI

Laboratory network to test vaccines against epidemic and pandemic diseases expands presence in Global South CEPI

Global Summit reinvigorates efforts to prepare for future pandemics CEPI

New clinical trial will assess if mpox vaccination works after virus exposure CEPI

Scientists explore innovative tech to rapidly make new vaccine antigens CEPI

CEPI Investors CEPI

Plague Inc. The Cure: Behind the scenes CEPI

CEPI and GHIC collaborate to advance vaccine R&D for emerging infectious diseases CEPI